AmberGen

About:

Transforming Diagnostics and Drug Discovery

Top Investors: MassVentures

Description:

AmberGen, Inc. is a privately-held, Boston-area company founded in 1995 to commercialize pioneering photonic technology developed at Boston University’s Molecular Biophysics Laboratory and the Photonics Center. The company’s mission is to innovate in the area of therapeutics and diagnostics by solving key problems that limit progress in medicine. AmberGen’s approach combines patented techniques in proteomics and light-based control of biomolecules.

Total Funding Amount:

$5.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Billerica, Massachusetts, United States

Founded Date:

1993-01-01

Contact Email:

info(AT)ambergen.com

Founders:

Kenneth Rothschild

Number of Employees:

11-50

Last Funding Date:

2023-06-30

IPO Status:

Private

Industries: